Table of Contents
1 INDUSTRY OUTLOOK 9
1.1 Industry overview 9
1.2 Industry Trends 9
2 Report Outline 10
2.1 Report Scope 10
2.2 Report Summary 11
2.3 Research Methodology 11
2.4 Report Assumptions 12
3 Market Snapshot 13
3.1 Market Definition - Infoholic Research 13
3.2 Advantages of Radiation Oncology 13
3.3 Side-effects of Radiation Oncology 13
3.4 Segmented Addressable Market (SAM) 13
3.5 Trends of the Radiation Oncology market 14
3.6 Related Markets 15
3.6.1 Cancer immunotherapy 15
3.6.2 Oncology drugs 16
4 Market Outlook 16
4.1 Overview 16
4.2 Funding scenario 17
4.3 Market segmentation 17
4.4 PEST Analysis 18
4.5 Porter 5(Five) Forces 20
5 Market Characteristics 21
5.1 DRO - Global Radiation Oncology Market Dynamics 21
5.1.1 Drivers 21
5.1.1.1 Growing incidence of cancer globally 21
5.1.1.2 Advancement in technology 22
5.1.2 Opportunities 22
5.1.2.1 Growing elderly population 22
5.1.2.2 Increasing adoption of non-invasive procedures in emerging countries 23
5.1.3 Restraints 24
5.1.3.1 Lack of trained technicians in developing countries 24
5.1.3.2 Side effects 24
5.1.3.3 High cost of instrument and therapy 24
6 Therapy type: Market Size and Analysis 27
6.1 Overview 27
6.2 External beam radiation therapy (EBRT) 29
6.2.1 By technology 29
6.2.1.1 Image-guided radiation therapy (IGRT) 30
6.2.1.2 Intensity-modulated radiation therapy (IMRT) 31
6.2.1.3 Volumetric modulated arc therapy (VMAT) 31
6.2.1.4 Stereotactic body radiation therapy (SBRT) 32
6.2.1.5 Intensity modulated proton therapy (IMPT) 32
6.2.1.6 Stereotactic radiosurgery (SRS) 33
6.2.1.7 Others 33
6.2.2 By Products 34
6.2.2.1 Linear accelerator (LINAC) 35
6.2.2.2 Proton therapy systems 35
6.3 Internal beam radiation therapy/Brachytherapy 36
6.3.1 By technology 37
6.3.1.1 High Dose Rate (HDR) brachytherapy 38
6.3.1.2 Low Dose Rate (LDR) brachytherapy 38
6.3.1.3 Others 38
6.3.2 By Products 39
6.3.2.1 Seeds 40
6.3.2.2 Applicators' afterloaders and other accessories 40
6.4 Systemic beam radiation therapy 41
7 Application: Market Size and Analysis 43
7.1 Overview 43
7.2 Prostate cancer 44
7.3 Cervical cancer 44
7.4 Breast cancer 45
7.5 Lung cancer 46
7.6 Head and Neck cancer 47
7.7 Brain cancer 47
7.8 Others 48
8 End Users: Market Size and Analysis 48
8.1 Overview 48
8.2 Hospitals 49
8.3 Radiation therapy centres 50
8.4 Ambulatory surgery centers 50
8.5 Others 50
9 Regions: Market Size and Analysis 51
9.1 Overview 51
9.2 North America 52
9.2.1 Overview 52
9.2.2 US 53
9.2.3 Canada 54
9.3 Europe 54
9.3.1 Overview 54
9.3.2 UK 55
9.3.3 Germany 56
9.3.4 France 56
9.3.5 Spain 56
9.4 APAC 57
9.4.1 Overview 57
9.4.2 India 57
9.4.3 China 58
9.4.4 Japan 59
9.5 Rest of the World 59
9.5.1 Overview 59
9.5.2 Brazil 60
9.5.3 Middle East 60
10 Competitive Landscape 61
10.1 Overview 61
11 Vendor Profiles 65
11.1 Accuray Incorporated 65
11.1.1 Overview 65
11.1.2 Geographic Presence 68
11.1.3 Business Focus 68
11.1.4 SWOT Analysis 69
11.1.5 Business Strategies 69
11.2 Elekta 70
11.2.1 Overview 70
11.2.2 Geographic Presence 73
11.2.3 Business Focus 73
11.2.4 SWOT Analysis 74
11.2.5 Business Strategy 74
11.3 Varian Medical Systems 75
11.3.1 Overview 75
11.3.2 Business Units 77
11.3.3 Geographic Presence 78
11.3.4 Business Focus 79
11.3.5 SWOT Analysis 79
11.3.6 Business Strategies 80
11.4 C. R. Bard' Inc. 81
11.4.1 Overview 81
11.4.2 Business Units 83
11.4.3 Business Focus 85
11.4.4 SWOT Analysis 85
11.4.5 Business Strategies 85
11.5 IBA worldwide 86
11.5.1 Overview 86
11.5.2 Business Units 88
11.5.3 Geographic Presence 89
11.5.4 Business Focus 90
11.5.5 SWOT Analysis 90
11.5.6 Business Strategies 91
12 Companies to Watch For 92
12.1 CARL ZEISS MEDITEC AG 92
12.1.1 Overview 92
12.1.2 Carl Zeiss Meditec AG: Recent Developments 93
12.2 Mevion Medical Systems 93
12.2.1 Overview 93
12.2.2 Mevion Medical Systems' Inc.: Recent Developments 93
12.3 Nordion' Inc. 94
12.3.1 Overview 94
12.3.2 Nordion' Inc.: Recent Developments 95
12.4 IsoRay' Inc. 96
12.4.1 Overview 96
12.4.2 IsoRay' Inc.: Recent Developments 97
12.5 Hitachi Medical Corporation 97
12.5.1 Overview 97
12.5.2 Hitachi Medical Corporation: Recent Developments 97
12.6 ViewRay' Inc. 98
12.6.1 Overview 98
12.6.2 ViewRay' Inc.: Recent Developments 99
13 Annexure 99
13.1 Abbreviations 99